36-months and 18-months relapse-free survival after (neo)adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma patients - update of the OpACIN and OpACIN-neo trials

Blank, CU (author)

Versluis, JM (author)

Rozeman, EA (author)

show more...

Menzies, AM (author)

Reijers, IL (author)

Krijgsman, O (author)

Hoefsmit, EP (author)

van de Wiel, BA (author)

Sikorska, K (author)

Bierman, C (author)

Dimitriadis, P (author)

Gonzalez, M (author)

Broeks, A (author)

Kerkhoven, RM (author)

Spillane, AJ (author)

Haanen, JB (author)

van Houdt, WJ (author)

Saw, RP (author)

Eriksson, H (author)

Karolinska Institutet

van Akkooi, AC (author)

Scolyer, RA (author)

Schumacher, TN (author)

Long, GV (author)

show less...

 (creator_code:org_t)

2020

2020

English.

In: CANCER RESEARCH. - 0008-5472. ; 80:16

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Conference paper (other academic/artistic)